Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2006 1
2007 1
2008 1
2009 3
2010 2
2012 1
2013 2
2014 2
2015 4
2016 1
2017 3
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in using circulating miRNAs as cancer biomarkers.
Tiberio P, Callari M, Angeloni V, Daidone MG, Appierto V. Tiberio P, et al. Among authors: appierto v. Biomed Res Int. 2015;2015:731479. doi: 10.1155/2015/731479. Epub 2015 Mar 22. Biomed Res Int. 2015. PMID: 25874226 Free PMC article. Review.
Circulating Biomarkers for Prediction of Treatment Response.
Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M, Daidone MG. Cappelletti V, et al. Among authors: appierto v. J Natl Cancer Inst Monogr. 2015 May;2015(51):60-3. doi: 10.1093/jncimonographs/lgv006. J Natl Cancer Inst Monogr. 2015. PMID: 26063889
Involvement of AF1q/MLLT11 in the progression of ovarian cancer.
Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V. Tiberio P, et al. Among authors: appierto v. Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574. Oncotarget. 2017. PMID: 28423573 Free PMC article.
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
Di Cosimo S, Appierto V, Pizzamiglio S, Silvestri M, Baselga J, Piccart M, Huober J, Izquierdo M, de la Pena L, Hilbers FS, de Azambuja E, Untch M, Pusztai L, Pritchard K, Nuciforo P, Vincent-Salomon A, Symmans F, Apolone G, de Braud FG, Iorio MV, Verderio P, Daidone MG. Di Cosimo S, et al. Among authors: appierto v. Int J Mol Sci. 2020 Feb 18;21(4):1386. doi: 10.3390/ijms21041386. Int J Mol Sci. 2020. PMID: 32085669 Free PMC article. Clinical Trial.
25 results